DCGI allows Biophore India to manufacture coronavirus drug Favipiravir API
Hyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read moreDetails
Hyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read moreDetailsNew Delhi: Biocon said Wednesday that its medical device to treat COVID-19 patient has received approval from the Drugs Controller ...
Read moreDetails
Aakar Patel I walk out of my house and onto the street and look around. Not much is different from...
Read moreDetails
Syed Ali Murtaza Rizvi’s decision to hang up his boots eight years ahead of time has clearly rattled the Telangana...
Read moreDetails
By Yuen Yuen Ang Conflicts, trade wars, inequality, and democratic decay fill today’s headlines. Each crisis appears to be feeding...
Read moreDetails
By Senem Aydın-Düzgit US President Donald Trump’s ferocious assault on American institutions over the last nine months is a particularly...
Read moreDetails